|
26 Companies |
|
24 Products |
|
24 Products |
|
22 Mechanisms of Action |
|
2 Trials |
|
625 News |
|
| «12345678910111213» |
- Trial primary completion date: RGN107: Wound Powder for Pressure Ulcers at End-of-life (clinicaltrials.gov) - Apr 14, 2015
P=N/A, N=50, Recruiting, Sponsor: Medical University of South Carolina
Trial primary completion date: Mar 2015 --> Oct 2015
- | aspirin / Generic mfg.
Enrollment open: Low Dose Aspirin for Venous Leg Ulcers (clinicaltrials.gov) - Apr 8, 2015
P3, N=354, Recruiting, Sponsor: University of Auckland, New Zealand
Trial primary completion date: Mar 2015 --> Oct 2015 Not yet recruiting --> Recruiting
- Enrollment closed, Trial primary completion date: A Multicenter, Post Marketing Clinical Follow up (PMCF) Investigation to Evaluate the Performance and Safety of a Soft Silicone Foam Dressing and to Evaluate the Performance of Standard Care in Exuding Venous Leg Ulcers (clinicaltrials.gov) - Apr 1, 2015
P=N/A, N=30, Active, not recruiting, Sponsor: Molnlycke Health Care AB
Not yet recruiting --> Recruiting Recruiting --> Active, not recruiting | Trial primary completion date: Sep 2014 --> Jul 2015
- Enrollment closed, Trial primary completion date: Pilot Study on Auricular Vagus Nerve Stimulation Effects in Chronic Diabetic Wounds (clinicaltrials.gov) - Apr 1, 2015
P=N/A, N=20, Active, not recruiting, Sponsor: Medical University of Vienna
Recruiting --> Active, not recruiting | Trial primary completion date: Sep 2014 --> Jul 2015 Recruiting --> Active, not recruiting | Trial primary completion date: Jan 2015 --> May 2015
- Enrollment closed: Safety Evaluation of the KLOX BioPhotonic System in Venous Leg Ulcers (clinicaltrials.gov) - Apr 1, 2015
P=N/A, N=10, Active, not recruiting, Sponsor: KLOX Technologies Inc.
Recruiting --> Active, not recruiting | Trial primary completion date: Jan 2015 --> May 2015 Recruiting --> Active, not recruiting
- Enrollment change: A Comparison of an Investigational Dressing to Tegaderm Matrix Wound Dressing in the Management of Diabetic Foot Ulcers (clinicaltrials.gov) - Mar 23, 2015
P=N/A, N=30, Terminated, Sponsor: 3M
Recruiting --> Active, not recruiting N=43 --> 30
- Enrollment open: LASER-1: Laser Therapy for Onychomycosis in Patients Wih Diabetes at Risk for Diabetic Foot Complications (clinicaltrials.gov) - Mar 17, 2015
P=N/A, N=64, Recruiting, Sponsor: Medical Research Foundation, The Netherlands
N=43 --> 30 Not yet recruiting --> Recruiting
- Enrollment change, Trial primary completion date: Urokinase Therapy in Patients With Diabetic Foot Syndrome (clinicaltrials.gov) - Mar 14, 2015
P3, N=5, Terminated, Sponsor: medac GmbH
Not yet recruiting --> Recruiting N=130 --> 5 | Trial primary completion date: May 2011 --> Jun 2009
- Trial completion: The Microbiologic Profile of Diabetic Foot Infections in Turkey - TURK-DAY (clinicaltrials.gov) - Mar 11, 2015
P=N/A, N=447, Completed, Sponsor: Gulhane Military Medical Academy
N=130 --> 5 | Trial primary completion date: May 2011 --> Jun 2009 Recruiting --> Completed
- | Trial termination: Safety and Efficacy Trial of HP802-247 in the Treatment of Chronic Venous Leg Ulcers (clinicaltrials.gov) - Feb 24, 2015
P3, N=440, Terminated, Sponsor: Smith & Nephew, Inc.
Recruiting --> Completed Active, not recruiting --> Terminated; based on outcome of trial NCT01656889.
- |||| Enrollment open, Trial primary completion date: A Pilot Trial of the Use of ReCell® Autologous Cell Harvesting Device for Venous Leg Ulcers (clinicaltrials.gov) - Feb 23, 2015
P4, N=65, Recruiting, Sponsor: Avita Medical
Active, not recruiting --> Terminated; based on outcome of trial NCT01656889. Not yet recruiting --> Recruiting | Trial primary completion date: Apr 2014 --> Sep 2015
- Enrollment closed, Trial primary completion date: CHEXU 01: Open, Non-comparative, Multi-centre Post Marketing Clinical Follow-up Investigation to Evaluate Performance and Safety on Diabetic Foot Ulcer, DFU When Using Fast Gelling Dressing as Intended. (clinicaltrials.gov) - Feb 23, 2015
P=N/A, N=25, Active, not recruiting, Sponsor: Molnlycke Health Care AB
Not yet recruiting --> Recruiting | Trial primary completion date: Apr 2014 --> Sep 2015 Recruiting --> Active, not recruiting | Trial primary completion date: Dec 2014 --> Apr 2015
- | Enrollment closed, Trial primary completion date: MxT Ag 05: TITLE: An Open, Non-comparative, Multi-centre Post Marketing Clinical Follow-up (PMCF) Investigation to Evaluate Performance and Safety on Diabetic Foot Ulcer, DFU, When Using Mepilex Transfer Ag as Intended (clinicaltrials.gov) - Feb 23, 2015
P4, N=30, Active, not recruiting, Sponsor: Molnlycke Health Care AB
Recruiting --> Active, not recruiting | Trial primary completion date: Dec 2014 --> Apr 2015 Recruiting --> Active, not recruiting | Trial primary completion date: Oct 2014 --> Apr 2015
- ||| Enrollment closed: AutoloGel Therapy to Usual and Customary Care in Pressure Ulcers (clinicaltrials.gov) - Feb 23, 2015
P4, N=400, Active, not recruiting, Sponsor: Cytomedix
Recruiting --> Active, not recruiting | Trial primary completion date: Oct 2014 --> Apr 2015 Recruiting --> Active, not recruiting
- ||| Enrollment closed: A Cohort Trial Comparing AutoloGel Therapy to Usual and Customary Care in Venous Leg Ulcers (clinicaltrials.gov) - Feb 23, 2015
P4, N=385, Active, not recruiting, Sponsor: Cytomedix
Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting
- ||| Enrollment closed: Effectiveness of AutoloGel Therapy in Diabetic Foot Ulcers (clinicaltrials.gov) - Feb 23, 2015
P4, N=380, Active, not recruiting, Sponsor: Cytomedix
Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting
- Enrollment change, Trial termination: PED111: Study of the Efficacy of PedyPhar® Ointment on the Diabetic Foot Ulcers (clinicaltrials.gov) - Feb 20, 2015
P3, N=47, Terminated, Sponsor: European Egyptian Pharmaceutical Industries
Recruiting --> Active, not recruiting N=120 --> 47 | Recruiting --> Terminated; inability to recruit patients
- Trial primary completion date: Phase IV Study to Evaluate the Efficacy of AMNIOEXCEL in Diabetic Foot Ulcers (clinicaltrials.gov) - Feb 19, 2015
P4, N=30, Recruiting, Sponsor: Derma Sciences, Inc.
N=120 --> 47 | Recruiting --> Terminated; inability to recruit patients Trial primary completion date: Dec 2014 --> May 2015
- |||||| gevokizumab (S 78989) / Novartis
Enrollment open: An Efficacy and Safety Study of Gevokizumab in Treating Active Ulcers of Pyoderma Gangrenosum (clinicaltrials.gov) - Feb 19, 2015
P3, N=58, Recruiting, Sponsor: XOMA (US) LLC
Trial primary completion date: Dec 2014 --> May 2015 Not yet recruiting --> Recruiting
- Enrollment open: Shockwave Therapy of Chronic Diabetic Foot Ulcers (clinicaltrials.gov) - Feb 19, 2015
P=N/A, N=30, Recruiting, Sponsor: Odense University Hospital
Not yet recruiting --> Recruiting Not yet recruiting --> Recruiting
- | New P1 trial: The Pharmacokinetic Study of WH-1 Ointment in Subjects With Chronic Diabetic Foot Ulcers (clinicaltrials.gov) - Feb 2, 2015
P1, N=12, Not yet recruiting, Sponsor: Oneness Biotech Co., Ltd.
- Trial initiation date, Trial primary completion date: [124I]FIAU PET-CT Scanning in Diagnosing Osteomyelitis in Patients With Diabetic Foot Infection (clinicaltrials.gov) - Jan 29, 2015
P2, N=4, Terminated, Sponsor: BioMed Valley Discoveries, Inc
Not yet recruiting --> Recruiting Initiation date: Jan 2013 --> Apr 2013 | Trial primary completion date: Dec 2013 --> Jul 2013
- Enrollment change, Trial termination: A Phase 2 Exploratory Pharmacodynamic Study of HP802-247 in Venous Leg Ulcers (clinicaltrials.gov) - Jan 29, 2015
P2, N=1, Terminated, Sponsor: Smith & Nephew, Inc.
Initiation date: Jan 2013 --> Apr 2013 | Trial primary completion date: Dec 2013 --> Jul 2013 N=25 --> 1 | Active, not recruiting --> Terminated; based on outcome of previous study
- |||| Enrollment open: AutoloGel Therapy to Usual and Customary Care in Pressure Ulcers (clinicaltrials.gov) - Jan 29, 2015
P4, N=400, Recruiting, Sponsor: Cytomedix
N=25 --> 1 | Active, not recruiting --> Terminated; based on outcome of previous study Not yet recruiting --> Recruiting
- Enrollment change: Evaluation of Fluorescence-image Guided Wound Assessment vs. Standard Practice (clinicaltrials.gov) - Jan 22, 2015
P=N/A, N=60, Enrolling by invitation, Sponsor: University Health Network, Toronto
Not yet recruiting --> Recruiting N=30 --> 60
- |||| Trial primary completion date: STRIDE 2: Phase 3 Study Evaluating Efficacy and Safety of DSC127 Compared With Vehicle and With Standard-of-care in Diabetic Foot Ulcers (clinicaltrials.gov) - Jan 15, 2015
P3, N=633, Recruiting, Sponsor: Derma Sciences, Inc.
N=30 --> 60 Trial primary completion date: Jul 2015 --> Mar 2016
- |||| Trial primary completion date: STRIDE 1: Phase III Study to Evaluate Efficacy and Safety of DSC127 in Diabetic Foot Ulcers (clinicaltrials.gov) - Jan 15, 2015
P3, N=422, Recruiting, Sponsor: Derma Sciences, Inc.
Trial primary completion date: Jul 2015 --> Mar 2016 Trial primary completion date: Jul 2015 --> Mar 2016
- || New P3 trial: ADHOC: The Sorbact® Antimicrobial Dressing in the Holistic Wound Management Of Diabetic Foot ulCers (Phase III Study) (clinicaltrials.gov) - Jan 8, 2015
P3, N=200, Recruiting, Sponsor: INRESA Pharma
- ||||| aspirin / Generic mfg.
New P2 trial: Aspirin for Venous Ulcers: Randomised Trial (AVURT) (clinicaltrials.gov) - Jan 7, 2015
P2, N=100, Not yet recruiting, Sponsor: St George's, University of London
- New P1 trial, HEOR: Hyperbaric Oxygen Therapy in Diabetics With Chronic Foot Ulcers and Improvement of Quality of Life (clinicaltrials.gov) - Jan 2, 2015
P1, N=38, Completed, Sponsor: Chen-Yu Chen
- Trial completion, Enrollment change, Trial primary completion date: Online Wound Electronic Medical Record (OWEMR) to Decrease Amputations in Diabetics (clinicaltrials.gov) - Jan 2, 2015
P=N/A, N=1609, Completed, Sponsor: New York University School of Medicine
Trial primary completion date: Jul 2015 --> Mar 2016 Recruiting --> Completed | N=4800 --> 1609 | Trial primary completion date: Mar 2014 --> Sep 2014
- |||||||||| gevokizumab (S 78989) / Novartis
New P3 trial: An Efficacy and Safety Study of Gevokizumab in Treating Active Ulcers of Pyoderma Gangrenosum (clinicaltrials.gov) - Dec 29, 2014
P3, N=58, Not yet recruiting, Sponsor: XOMA (US) LLC
- Trial primary completion date: HADIF: HELP-Apheresis in Diabetic Ischemic Foot Treatment (H.A.D.I.F) (clinicaltrials.gov) - Dec 24, 2014
P=N/A, N=132, Recruiting, Sponsor: Universita di Verona
Recruiting --> Completed | N=4800 --> 1609 | Trial primary completion date: Mar 2014 --> Sep 2014 Trial primary completion date: Jan 2015 --> Jan 2017
- |||||||||| gevokizumab (S 78989) / Novartis
New P3 trial: A 2-Year, Open-Label, Safety Extension Study of Gevokizumab in Subjects With Pyoderma Gangrenosum (clinicaltrials.gov) - Dec 19, 2014
P3, N=100, Enrolling by invitation, Sponsor: XOMA (US) LLC
- New P1 trial: DFUPS: Diabetic Foot Ulcer Prevention System (clinicaltrials.gov) - Dec 19, 2014
P1, N=100, Not yet recruiting, Sponsor: King's College Hospital NHS Trust
- Trial initiation date: Shockwave Therapy of Chronic Diabetic Foot Ulcers (clinicaltrials.gov) - Dec 17, 2014
P=N/A, N=30, Not yet recruiting, Sponsor: Odense University Hospital
Trial primary completion date: Jan 2015 --> Jan 2017 Initiation date: Oct 2014 --> Jan 2015
- cenplacel (PDA-002) / Celularity
Enrollment closed: Study of Human Placenta-derived Cells (PDA002) to Evaluate the Safety and Effectiveness in Subjects With PAD and DFU (clinicaltrials.gov) - Dec 17, 2014
P1, N=24, Active, not recruiting, Sponsor: Celgene Corporation
Initiation date: Oct 2014 --> Jan 2015 Recruiting --> Active, not recruiting
- Trial completion, Enrollment change, Trial primary completion date: Surface NeuroMuscular Electrical Stimulation in the Treatment of Chronic Venous Leg Ulcers (clinicaltrials.gov) - Dec 13, 2014
P2, N=25, Completed, Sponsor: Professor Stewart Walsh
Recruiting --> Active, not recruiting Recruiting --> Completed | N=50 --> 25 | Trial primary completion date: Mar 2014 --> Sep 2014
- |||||||||| gevokizumab (S 78989) / Novartis
New P3 trial: An Efficacy and Safety Study of Gevokizumab in Treating Active Ulcers of Pyoderma Gangrenosum (clinicaltrials.gov) - Dec 11, 2014
P3, N=58, Recruiting, Sponsor: XOMA (US) LLC
- chlorhexidine gluconate / Generic mfg.
Enrollment open: Diabetic Foot Ulcer. Effectiveness of Chlorhexidine Gluconate 0.125 % Compared With Sterile Deionized Water (clinicaltrials.gov) - Dec 7, 2014
P4, N=80, Recruiting, Sponsor: Universidad de Guanajuato
Recruiting --> Completed | N=50 --> 25 | Trial primary completion date: Mar 2014 --> Sep 2014 Not yet recruiting --> Recruiting
- ||||||| Trial completion: Study Investigating the Safety and Efficacy of HP802-247 in the Treatment of Venous Leg Ulcers (clinicaltrials.gov) - Dec 6, 2014
P3, N=447, Completed, Sponsor: Healthpoint
Not yet recruiting --> Recruiting Active, not recruiting --> Completed
- Trial completion, Trial initiation date: Measurement of Cytokines (IL-1α) After Shear- Force Application at the Skin (clinicaltrials.gov) - Dec 5, 2014
P=N/A, N=10, Completed, Sponsor: Maastricht University Medical Center
Active, not recruiting --> Completed Not yet recruiting --> Completed | Initiation date: Feb 2014 --> Nov 2014
- Trial primary completion date: Topical Sodium Nitrite for Chronic Leg Ulcers in Adult Patients With Blood Disorders (clinicaltrials.gov) - Nov 28, 2014
P1, N=44, Recruiting, Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Not yet recruiting --> Completed | Initiation date: Feb 2014 --> Nov 2014 Trial primary completion date: Apr 2015 --> Apr 2016
- ||| Enrollment open: Trial of Dehydrated Human Amnion/Chorion Membrane (dHACM) In the Management of Diabetic Foot Ulcers (clinicaltrials.gov) - Nov 24, 2014
P=N/A, N=84, Recruiting, Sponsor: MiMedx Group, Inc.
Trial primary completion date: Apr 2015 --> Apr 2016 Active, not recruiting --> Recruiting
- |||||| Enrollment open: A Phase 3 Clinical Trial to Assess the Effectiveness of BioChaperone PDGF-BB In the Treatment of Chronic Diabetic Foot Ulcer (clinicaltrials.gov) - Nov 24, 2014
P3, N=252, Recruiting, Sponsor: Adocia
Active, not recruiting --> Recruiting Not yet recruiting --> Recruiting
- ||||| Enrollment closed: Safety and Efficacy Trial of HP802-247 in the Treatment of Chronic Venous Leg Ulcers (clinicaltrials.gov) - Nov 20, 2014
P3, N=440, Active, not recruiting, Sponsor: Smith & Nephew, Inc.
Not yet recruiting --> Recruiting Recruiting --> Active, not recruiting
- Trial primary completion date: Pilot Study on Auricular Vagus Nerve Stimulation Effects in Chronic Diabetic Wounds (clinicaltrials.gov) - Nov 19, 2014
P=N/A, N=20, Recruiting, Sponsor: Medical University of Vienna
Recruiting --> Active, not recruiting Trial primary completion date: Oct 2014 --> Jan 2015
- | Enrollment closed: A Phase 2 Exploratory Pharmacodynamic Study of HP802-247 in Venous Leg Ulcers (clinicaltrials.gov) - Nov 19, 2014
P2, N=25, Active, not recruiting, Sponsor: Smith & Nephew, Inc.
Trial primary completion date: Oct 2014 --> Jan 2015 Recruiting --> Active, not recruiting
- || Trial primary completion date: ORTHODIAB: Evaluation of a New Device "Orth (clinicaltrials.gov) - Nov 18, 2014
P=N/A, N=110, Recruiting, Sponsor: Proteor Group
Recruiting --> Active, not recruiting Trial primary completion date: May 2014 --> May 2016
- |||| Trial primary completion date: Study Investigating the Safety and Efficacy of HP802-247 in the Treatment of Venous Leg Ulcers (clinicaltrials.gov) - Nov 17, 2014
P3, N=440, Active, not recruiting, Sponsor: Healthpoint
Trial primary completion date: May 2014 --> May 2016 Trial primary completion date: May 2014 --> Jan 2015